Literature DB >> 16683991

Haemophilia and ageing.

A Street1, K Hill, B Sussex, M Warner, M-F Scully.   

Abstract

Men with haemophilia have not only the challenges of living with HIV and/or HCV infection and premature arthritis as complications of their disorder, but they also confront the other ails of ageing. These include genitourinary problems such as prostatic hypertrophy, prostatic cancer and renal stone disease, and arterial disease for which haemophilia is not protective. Progressive arthritis and declining fitness may lead to loss of independence which causes great concern. Associated with the physical aspects of ageing, many patients also suffer from psychological symptoms which may be precipitated by changes in work such as early retirement and altered family dynamics. Many older men with haemophilia may never have consulted primary care physicians because of the rarity and complexity of their disorder. Haemophilia centre staff often assume responsibility for the identification and management of all health problems of their patients. Even when other clinicians are involved, patients require their centre's involvement in the investigation and support of many procedures such as coronary artery surgery and urological surgery. This paper addresses falls in the older man with haemophilia, their causes and consequences and cardiovascular problems in particular. Very little literature has been published about these common problems. We need to be aware of the ageing issues in haemophilia and develop 'wellness' programs which are directed to the early identification of disease as well as preventative strategies to reduce the physical and psychological impacts of ageing.

Entities:  

Mesh:

Year:  2006        PMID: 16683991     DOI: 10.1111/j.1365-2516.2006.01254.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  8 in total

1.  Haemophilia at various stages of life: design of new therapeutic strategies through an interactive course--the Kogeniale project.

Authors:  Elena Santagostino; Maria Messina; Annarita Tagliaferri; Alfonso Iorio; Massimo Morfini
Journal:  Blood Transfus       Date:  2013-01-23       Impact factor: 3.443

Review 2.  Management of Hemophilia in Older Patients.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

3.  Promoting physical activity in people with haemophilia: the MEMO (Movement for persons with haEMOphilia) expert consensus project.

Authors:  Chiara Biasoli; Erminia Baldacci; Antonio Coppola; Raimondo De Cristofaro; Matteo N D Di Minno; Giuseppe Lassandro; Silvia Linari; Maria E Mancuso; Mariasanta Napolitano; Gianluigi Pasta; Angiola Rocino
Journal:  Blood Transfus       Date:  2021-10-15       Impact factor: 3.443

4.  Multiple Comorbid Conditions among Middle-Aged and Elderly Hemophilia Patients: Prevalence Estimates and Implications for Future Care.

Authors:  Aroub A Khleif; Nidra Rodriguez; Deborah Brown; Miguel A Escobar
Journal:  J Aging Res       Date:  2011-09-07

5.  First Report of Prevalence of Blood-Borne Viruses (HBV, HCV, HIV, HTLV-1 and Parvovirus B19) Among Hemophilia Patients in Afghanistan.

Authors:  Sayed Hamid Mousavi; Niloofar Khairkhah; Tina Delsouz Bahri; Ali Anvar; Alireza Azizi Saraji; Bita Behnava; Seyed Moayed Alavian; Ali Namvar
Journal:  Sci Rep       Date:  2019-05-13       Impact factor: 4.379

6.  Economic burden of high-responding inhibitors in patients with hemophilia A in Taiwan.

Authors:  Tsu-Chiang Tu; Shin-Nan Cheng; Jye-Daa Chen; Thau-Ming Cham; Mei-Ing Chung
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

7.  Prevalence, incidence, and factor concentrate usage trends of hemophiliacs in Taiwan.

Authors:  Tsu-Chiang Tu; Wen-Shyong Liou; Tsui-Yun Chou; Tsung-Kun Lin; Chuan-Fang Lee; Jye-Daa Chen; Thau-Ming Cham; Mei-Ing Chung
Journal:  Yonsei Med J       Date:  2013-01-01       Impact factor: 2.759

Review 8.  The management of hemophilia in elderly patients.

Authors:  Massimo Franchini; Annarita Tagliaferri; Pier Mannuccio Mannucci
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.